Markey, K., Mitchell, J., Botfield, H., Ottridge, R. S., Matthews, T., Krishnan, A., . . . Sinclair, A. J. (2020). 11β-Hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: A double-blind randomized controlled trial. Brain communications, 2(1), fcz050. https://doi.org/10.1093/braincomms/fcz050
Chicago Style (17th ed.) CitationMarkey, Keira, et al. "11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition in Idiopathic Intracranial Hypertension: A Double-blind Randomized Controlled Trial." Brain Communications 2, no. 1 (2020): fcz050. https://doi.org/10.1093/braincomms/fcz050.
MLA (9th ed.) CitationMarkey, Keira, et al. "11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition in Idiopathic Intracranial Hypertension: A Double-blind Randomized Controlled Trial." Brain Communications, vol. 2, no. 1, 2020, p. fcz050, https://doi.org/10.1093/braincomms/fcz050.